Live feed06:35:00·1576dPRReleasevia QuantisnowPureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022ByQuantisnow·Wall Street's wire, on your screen.CPSR· Capstar Special Purpose Acquisition Corp.GLS· Gelesis Holdings Inc.PRTC· PureTech Health plcFinanceHealth Care
